PERI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 35.941
EU - Europa 20.921
AS - Asia 10.900
SA - Sud America 1.525
AF - Africa 273
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 20
Totale 69.616
Nazione #
US - Stati Uniti d'America 34.954
DE - Germania 5.624
SE - Svezia 4.595
SG - Singapore 3.356
IT - Italia 2.919
DK - Danimarca 2.820
CN - Cina 2.508
VN - Vietnam 1.804
HK - Hong Kong 1.305
RU - Federazione Russa 1.205
BR - Brasile 1.187
CA - Canada 827
IE - Irlanda 630
GB - Regno Unito 547
FR - Francia 535
UA - Ucraina 534
PL - Polonia 412
IN - India 405
BD - Bangladesh 252
FI - Finlandia 244
AT - Austria 237
KR - Corea 201
NL - Olanda 185
ID - Indonesia 158
TR - Turchia 142
JP - Giappone 126
IQ - Iraq 123
ES - Italia 117
AR - Argentina 101
BE - Belgio 98
PK - Pakistan 95
MX - Messico 93
ZA - Sudafrica 88
SA - Arabia Saudita 55
EC - Ecuador 54
PH - Filippine 48
CO - Colombia 47
UZ - Uzbekistan 42
CH - Svizzera 40
VE - Venezuela 40
CL - Cile 37
RO - Romania 36
MY - Malesia 32
MA - Marocco 31
LT - Lituania 29
EG - Egitto 28
AU - Australia 27
IR - Iran 27
TW - Taiwan 26
KE - Kenya 24
AE - Emirati Arabi Uniti 23
PY - Paraguay 23
ET - Etiopia 22
JO - Giordania 21
NP - Nepal 21
TN - Tunisia 21
IL - Israele 19
DZ - Algeria 18
AZ - Azerbaigian 17
CZ - Repubblica Ceca 15
PT - Portogallo 15
GR - Grecia 14
PE - Perù 13
EU - Europa 12
LB - Libano 12
TH - Thailandia 12
DO - Repubblica Dominicana 10
JM - Giamaica 10
UY - Uruguay 10
AL - Albania 9
BO - Bolivia 9
CR - Costa Rica 9
HU - Ungheria 8
KZ - Kazakistan 8
NO - Norvegia 8
NZ - Nuova Zelanda 8
OM - Oman 8
PS - Palestinian Territory 8
BB - Barbados 7
BG - Bulgaria 7
KG - Kirghizistan 7
LV - Lettonia 7
PA - Panama 7
RS - Serbia 7
TT - Trinidad e Tobago 7
MU - Mauritius 6
SY - Repubblica araba siriana 6
MD - Moldavia 5
NG - Nigeria 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
AO - Angola 4
BY - Bielorussia 4
GE - Georgia 4
GY - Guiana 4
NI - Nicaragua 4
SC - Seychelles 4
SN - Senegal 4
BH - Bahrain 3
CI - Costa d'Avorio 3
Totale 69.546
Città #
Ann Arbor 19.992
Frankfurt am Main 5.173
Stockholm 3.748
Singapore 1.888
Ashburn 1.599
Hong Kong 1.252
Woodbridge 1.151
Wilmington 1.093
San Jose 1.001
Chandler 942
Fairfield 884
Milan 869
Houston 618
Dublin 603
Toronto 542
Jacksonville 507
Ho Chi Minh City 493
Seattle 373
Hanoi 367
Beijing 349
Santa Clara 339
Kraków 329
Dearborn 311
Los Angeles 309
New York 290
Rome 276
Chicago 271
Hefei 270
Cambridge 268
Princeton 232
Council Bluffs 226
Dong Ket 220
Vienna 210
Nanjing 191
Boardman 189
Seoul 181
The Dalles 179
Dallas 171
Shanghai 154
São Paulo 137
Altamura 131
Guangzhou 131
Lauterbourg 121
Jakarta 120
Buffalo 117
Lawrence 107
Helsinki 103
Tokyo 91
Brussels 85
San Diego 82
Lachine 80
Moscow 80
Orem 74
Florence 61
Munich 61
London 58
Chennai 56
Amsterdam 54
Warsaw 54
Da Nang 53
Montreal 52
Ottawa 50
Hangzhou 48
Washington 48
Johannesburg 47
Brooklyn 46
Hyderabad 46
Jinan 46
Baghdad 45
Fremont 45
Haiphong 45
Tianjin 44
Denver 42
Falls Church 42
Phoenix 41
Nuremberg 40
Turin 40
Montréal 39
Shenyang 39
Tashkent 39
Hebei 38
Atlanta 37
Nanchang 37
Rio de Janeiro 37
Andover 36
Dhaka 36
Changsha 35
Paris 34
Brasília 31
Brescia 31
Piscataway 31
Boston 30
Biên Hòa 29
Columbus 29
Huizen 29
Kent 29
Manchester 29
San Francisco 29
Norwalk 28
Salt Lake City 28
Totale 51.443
Nome #
Representative secondary PET micro and nanoplastics via ethylene glycol fragmentation (EGF): Physicochemical and immuno-toxicological properties 1.934
Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives 1.912
Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties 831
Synthetic and natural small molecule TLR4 antagonists inhibit motoneuron death in cultures from ALS mouse model 803
Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists 798
Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation 793
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-RasG13D 745
Structural characterization of aerogels derived from enzymatically oxidized galactomannans of fenugreek, sesbania and guar gums 735
Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)-and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling 730
TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection 710
Recent advances on Toll-like receptor 4 modulation: new therapeutic perspectives 694
A new advanced cellular model of functional cholinergic-like neurons developed by reprogramming the human SH-SY5Y neuroblastoma cell line 684
First experimental identification of Ras-inhibitor binding interface using a water-soluble Ras ligand 679
Dye-sensitized photocatalytic hydrogen production: Distinct activity in a glucose derivative of a phenothiazine dye 677
The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells 677
The Role of TLR4 in Neural Stem Cells–Mediated Neurogenesis and Neuroinflammation 675
Functional characterization of E. coli LptC: Interaction with LPS and a synthetic ligand 674
Co-administration of Antimicrobial Peptides Enhances Toll-like Receptor 4 Antagonist Activity of a Synthetic Glycolipid 659
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 651
The role of carbohydrates in the lipopolysaccharide (LPS)/toll-like receptor 4 (TLR4) Signalling 642
Synthesis of the New Cyanine-Labeled Bacterial Lipooligosaccharides for Intracellular Imaging and in Vitro Microscopy Studies 639
Glucose-derived Ras pathway inhibitors: evidence of Ras-ligand binding and Ras-GEF (Cdc25) interaction inhibition 633
Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic 631
Dye-Sensitized Photocatalytic Hydrogen Generation: Efficiency Enhancement by Organic Photosensitizer-Coadsorbent Intermolecular Interaction 629
Binding properties and biological characterization of new sugar-derived Ras ligands 628
Glycolipids and benzylammonium lipids as novel antisepsis agents: Synthesis and biological characterization 617
Glycolipid-based TLR4 Modulators and Fluorescent Probes: Rational Design, Synthesis, and Biological Properties 611
Exploring the LPS/TLR4 signal pathway with small molecules 609
Structure and inflammatory activity of the LPS isolated from Acetobacter pasteurianus CIP103108 609
Uniform lipopolysaccharide (LPS)-loaded magnetic nanoparticles for the investigation of LPS-TLR4 signaling 602
Trehalose- and glucose-derived glycoamphiphiles: Small-molecule and nanoparticle toll-like receptor 4 (TLR4) modulators 600
Metabolism of Phosphatidylinositol 4-Kinase IIIα-Dependent PI4P Is Subverted by HCV and Is Targeted by a 4-Anilino Quinazoline with Antiviral Activity 599
Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice 593
Toll-like Receptor 4 (TLR4) Modulation by Synthetic and Natural Compounds: An Update 593
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 591
A Synthetic Lipid A Mimetic Modulates Human TLR4 Activity 584
TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis 582
Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists 581
Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis 577
Hemin and a metabolic derivative coprohemin modulate the TLR4 pathway differently through different molecular targets 576
Synthesis and biological evaluation of novel lipid A antagonists 567
The cationic amphiphile 3,4-bis (tetradecyloxy) benzylamine inhibits LPS signaling by competing with endotoxin for CD14 binding 563
Synthetic molecules and functionalized nanoparticles targeting the LPS-TLR4 signaling: a new generation of immunotherapeutics 556
A new isoluminol reagent for chemiluminescence labeling of proteins 553
How do viruses interfere with Toll-like receptor 4? 551
Inhibition of lipid A stimulated activation of human dendritic cells and macrophages by amino and hydroxylamino monosaccharides 539
Evidence of a specific interaction between new synthetic antisepsis agents and CD14 537
Sugar-derived Ras inhibitors: Group epitope mapping by NMR spectroscopy and biological evaluation 534
Modulation of LPS signaling through TLR4 agonists and antagonists 534
Design and characterisation of a new class of inhibitors of Ras activation 530
The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling 525
Design, Synthesis and Biological Evaluation of Levoglucosenone-derived Ras Activation Inhibitors 519
Rigid polycycles and peptidomimetics from carbohydrate synthons 517
Compound for the covalent attachment of the chemiluminescent probe N-(4-Aminobutyl)-N-ethylisoluminol (ABEI) to target molecules and uses thereof 516
Multivalent glycoconjugates as anti-pathogenic agents 516
Clustered carbohydrates in synthetic vaccines 512
Optimizing operating conditions and electrochemical characterization of glucose-gluconate alkaline fuel cells 508
Design, synthesis and biological evaluation of sugar-derived Ras inhibitors 503
Carbohydrate-based bioactive compounds for medicinal chemistry applications 503
Editorial 497
Arabinose-derived Bicyclic Amino Acids: Synthesis, Conformational Analysis and Construction of an avb3-selective RGD Peptide 492
Glycoconjugates in cancer therapy 491
Chemoselective neoglycosylation 490
Carbohydrate Scaffolds for the Production of Bioactive Compounds 488
Novel α-conotoxin from Conus spurius and the α-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcoline receptors 487
NEW SYNTHETIC AGONISTS OF TLR4 RECEPTOR 486
Chemistry of lipid a: At the heart of innate immunity 485
A novel small molecule TLR4 antagonist (IAXO-102) negatively regulates non-hematopoietic toll like receptor 4 signalling and inhibits aortic aneurysms development 478
Clicked and long spaced galactosyl- and lactosylcalix[4]arenes: New multivalent galectin-3 ligands 475
Synthesis and biological evaluation of an anticancer vaccine containing the C-glycoside analogue of the Tn epitope 473
Looking forward: A glance into the future of organic chemistry 472
Studies on the mechanism of action of a new class of inhibitors of Ras activation 469
Sugar-derived amino acids: powerful secondary structure inducing elements in the design of novel peptidomimetics 468
Polycyclic Scaffolds from Fructose 464
Solution and solid-phase chemoselective synthesis of (1-6)-amino(methoxy) di- and trisaccharide analogues 463
Glycoconjugate and oligosaccharide mimetics by chemoselective ligation 462
Chemoselective Ligation in Glycochemistry 462
Extending chemoselective ligation to sugar chemistry:convergent assembly of bioactive neoglycoconjugates 462
Sugar-Based Inhibitors of Ras Activation: Biological Activity and Identification of Ras–Inhibitor Binding Interface 460
Synthesis of imino sugar scaffolds for the generation of glycosidase inhibitor libraries 458
Synthesis of bicyclic sugar azido acids and their incorporation in cyclic peptides 456
Molecular simplification of lipid A structure: TLR4-modulating cationic and anionic amphiphiles 455
Assembly of binding loops on aromatic templates as V CAM-1 mimetics 454
Synthesis of imino-C-disaccharides related to sucrose 451
Conversion of lactose into mimics of N-acetyllactosamine 446
Discrimination Properties of Tetraamidic Branched Selectors 446
Carbohydrate-based Scaffolds for the generation of sortiments of bioactive compounds 444
A new procedure for the synthesis of C-glycosides of nojirimycin 441
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants 441
Chemoselective glycosylation techniques for the synthesis of bioactive neoglycoconjugates, glyconanoparticles and glycoarrays 440
The EuroSciCon's 2015 Innate Immunity Summit 440
Lipid A antagonists with anti-septic shock, anti-inflammatory, anti-ischemia and analgesic activity 438
Stepwise synthesis and structural characterization of calix[4]- and calix[5]arenes bearing a functionalized arm on the methylene bridge 437
D-glucose as a regioselectively addressable scaffold for combinatorial chemistry on solid phase 436
Stereoselective synthesis of α-C-glycosides of N-acetylgalactosamine 432
Green and Roasted Coffee Extracts Inhibit Interferon-β Release in LPS-Stimulated Human Macrophages 430
Regioselection and orthogonality of the 1-phenyl-3-butenyl (PBU) protecting group in glucopyranosides 429
The bone morphogenic protein antagonist Drm/gremlin is a novel pro- angiogenic factor 429
Glycidic scaffolds in Peptidomimetic synthesis 427
Tin-mediated regioselective acylation of unprotected sugars on solid phase 424
Totale 57.648
Categoria #
all - tutte 159.956
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.956


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.249 0 0 0 0 0 0 0 0 0 0 0 1.249
2021/202211.080 1.142 1.083 967 1.112 887 869 785 847 676 868 787 1.057
2022/20238.296 1.376 1.724 1.100 997 928 1.111 161 295 250 175 104 75
2023/20242.842 84 188 345 160 351 433 448 141 184 86 110 312
2024/20256.194 324 548 455 326 461 300 334 353 588 926 547 1.032
2025/202618.838 1.885 981 1.133 1.638 1.611 788 2.028 676 1.588 5.207 986 317
Totale 71.018